Skip to main content
SpringerLink
Log in
Book cover

Office Gynecology pp 167–174Cite as

Management of Menopause, Including Hormonal Replacement Therapy

  • Chapter

  • 101 Accesses

Abstract

In 1900, only 3.1 million people in the United States were 65 or older. In 1980, 25 million were 65 or older, some 10 million of whom were 75 or older. By 2025, it is estimated that almost 60 million individuals will be over age 65 and about 30 million will be over age 75. In the past, women did not live long enough to reach the age of normal menopause. Only recently has the life span of the human encompassed the postmenopausal years; therefore, the complications associated with menopause rarely occurred.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Christiansen C, ed. Consensus development conference on osteoporosis Am J Med. 1991; 91(5B):68.

    Google Scholar 

  2. Albright F. Osteoporosis. Ann Int Med. 1947; 27: 861–882.

    PubMed  CAS  Google Scholar 

  3. Riggs BL, Melton LJ III. Evidence for two distinct syndromes of ihvolutional osteoporosis Am J Med. 1983; 75: 899–901.

    Article  PubMed  CAS  Google Scholar 

  4. Genant HK, Faulkner KG, Gluer CC. Measurement of bone mineral density: current status. Am J Med. 1991; 91 (5B): 49–53.

    Article  Google Scholar 

  5. Hazzard WR. Estrogen replacement and cardiovascular Disease: serum lipids and blood pressure effects Am J Obstet Gynecol. 1989; 161: 1847.

    PubMed  CAS  Google Scholar 

  6. Wolf PH, Madans JH, Finucane FF, Higgins M, Kleinman JC. Reduction of cardiovascular disease-related mortality among postmeopausal women who use hormones: evidence from a national cohort. Am J Obstet Gynecol. 1991; 164 (2): 489–494.

    PubMed  CAS  Google Scholar 

  7. Hirvonen E, Malkonen M, Manninen V. Effects of different progestagens on lipoproteins during postmenopausal replacement therapy. N Engl J Med. 1981; 304: 560–563.

    Article  PubMed  CAS  Google Scholar 

  8. Notelovitz M. Estrogen replacement therapy: indications, contraindications and agent selection. Am J Obstet Gynecol. 1989; 161: 1832 1841.

    Google Scholar 

  9. Erikssen ER, Colvard DS, Berg NJ, et al. Evidence of estrogen receptors in normal human osteoblast-like cells. Science. 1988; 241: 84–86.

    Article  Google Scholar 

  10. Lindsay R. Sex steroids in the pathogenesis and prevention of osteoporosis. In: Riggs BL, Melton LJ III, eds. Osteoporosis: Etiology, Diagnosis and Management. New York: Raven Press; 1988: 335–358.

    Google Scholar 

  11. Consensus development conference: prophylaxis and treatment of osteoporosis. Am J Med. 1991;90:107–110.

    Google Scholar 

  12. Cummings SR. Evaluating the benefits and risks and postmenopausal hormone therapy. Am J Med. 1991; 91 (5B): 14–18.

    Article  Google Scholar 

  13. Padwick MB Pryse-Davies J, Whitehead MI. A simple method for determining the optimal dosage of progestin in postmenopausal women receiving estrogen. New Engl J Med. 1986; 315: 930.

    Google Scholar 

  14. Whitehead MI, Hillard TC, Crook D. The role and use of progestogens. Obstet Gynecol. 1990; 75: 59S - 76S.

    PubMed  CAS  Google Scholar 

  15. Henderson BE. The cancer question: An overview of recent epidemiologic and retrospective data. Am J Obstet Gynecol. 1989; 161: 1859.

    PubMed  CAS  Google Scholar 

  16. Dupont W, Page, D. Menopausal estrogen replacement therapy and breast cancer. Arch Intern Med. 1991; 151: 57–72.

    Article  Google Scholar 

  17. Nachtigall LE. Estrogen and breast cancer. Current Perspectives on Managing the Menopausal and Post-Menopausal Patient: A Symposium. Ciba Pharmaceutical Company. Irving, Texas, December 8, 1990.

    Google Scholar 

  18. Storm T, Thamsborg G, Steiniche T, Genant HK, Sorensen OH. Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis. New Engl J Med. 1990; 332: 1265–1271.

    Article  Google Scholar 

  19. Watts N, Harris ST, Genant HK, et al. Intermittent cyclical etidronate treatment of postmenopausal osteoporosis. New Engl J Med. 1990; 323: 73–79.

    Article  PubMed  CAS  Google Scholar 

  20. Parfitt AM. Use of biphosphonates in the prevention of bone loss and fractures. Am J Med. 1991; 91 (5B): 49–53.

    Google Scholar 

  21. Reginster JY. Effect of calcitonin on bone mass and fracture rates. Am J Med. 1991; 91 (5B): 23–28.

    Google Scholar 

  22. Riggs BL. Treatment of osteoporosis with sodium fluoride or parathyroid hormone. Am J Med. 1991; 91 (5B): 37–41.

    Article  Google Scholar 

Download references

Authors
  1. Erica G. Sinsheimer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Pauline J. Shipley
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jay J. Gold
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Stritch School of Medicine, Loyola University of Chicago, Maywood, IL, 60153, USA

    John V. Knaus D.O. (Clinical Associate Professor of Obstetrics and Gynecology, Chairman, Chief) & John H. Isaacs M.D. (Professor of Obstetrics and Gynecology, Gynecologist-in-Chief) (Clinical Associate Professor of Obstetrics and Gynecology, Chairman, Chief) &  (Professor of Obstetrics and Gynecology, Gynecologist-in-Chief)

  2. Department of Obstetrics and Gynecologic, St. Francis Hospital, Evanston, IL, 60202, USA

    John V. Knaus D.O. (Clinical Associate Professor of Obstetrics and Gynecology, Chairman, Chief) (Clinical Associate Professor of Obstetrics and Gynecology, Chairman, Chief)

  3. Section of Gynecologic Oncology, St. Francis Hospital, Evanston, IL, 60202, USA

    John V. Knaus D.O. (Clinical Associate Professor of Obstetrics and Gynecology, Chairman, Chief) (Clinical Associate Professor of Obstetrics and Gynecology, Chairman, Chief)

  4. St. Francis Hospital, Evanston, IL, 60202, USA

    John H. Isaacs M.D. (Professor of Obstetrics and Gynecology, Gynecologist-in-Chief) (Professor of Obstetrics and Gynecology, Gynecologist-in-Chief)

Rights and permissions

Reprints and permissions

Copyright information

© 1993 Springer-Verlag New York, Inc.

About this chapter

Cite this chapter

Sinsheimer, E.G., Shipley, P.J., Gold, J.J. (1993). Management of Menopause, Including Hormonal Replacement Therapy. In: Knaus, J.V., Isaacs, J.H. (eds) Office Gynecology. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-4340-3_13

Download citation

  • DOI: https://doi.org/10.1007/978-1-4612-4340-3_13

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4612-8740-7

  • Online ISBN: 978-1-4612-4340-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation